The SAT's order on Tuesday to give its nod to Fresenius Oncology for delisting its shares without having the need to go ahead with the stiff conditions put forth by the Sebi is anti-investor and patently wrong, belives JN Gupta.
first published: Sep 11, 2013 01:43 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Headed For All-Time Highs After Friday’s Late Recovery?| Opening Bell Live
This Tenant Moved from a 100sqft Slum to a Premium Residence | The Tenant
Live: Nifty snaps 4-day winning streak but rises 1% this week | Closing Bell
Live: Can Bihar poll outcome trigger Nifty to reclaim 26,000-mark? | Opening Bell
